Technology

COVID-19 pandemic is accelerating cultural paradigm shift for medical professionals

Machine-learning algorithms have potential to predict patients with nonproliferative diabetic retinopathy who will or will not improve over time.

Study results demonstrate effectiveness in treating dry age-related macular degeneration

Researchers must weigh emotional, financial, and reputational considerations

Technology is off to a good start, but improvements still needed

ASRS 2020 coverage: An augmented-reality device provides AMD patients with enhanced reading ability and facial recognition.

During the COVID-19 pandemic, it is important to develop technologies to keep patients and staff safe, while treating the diseases of the eye

With an eye on innovation, money is driving research of new therapies and devices.

Industry develops creative approaches to help increase patient medication adherence

Just as evolving technology is changing patients' visual demands, eye-care providers should increase their awareness and efforts to fill current gaps.

Panel discusses IOP monitoring, drug delivery, data collection

Research finds automated segmentation software examines OCT scans

ICYMI: Nir Israeli, co-founder and CEO of Sanoculis discusses the company's new alternative surgical procedure for glaucoma designed to create a single-patient-use sterile tool and a multi-use external machine.

ICYMI: Chris Adams, CEO of Diopter Corp, discusses the company's drug delivery contact lens technology in the pipeline that works to treat ocular surface disease, during the 2020 Glaucoma 360 meeting in San Francisco, California.

High-level observations for how the latest developments can help glaucoma specialists solve problems to achieve the utmost in patient care

New products increase the chance of early diagnosis

Physicians can discover, diagnose, document, treat diseases that might go undetected

ICYMI: Daria Lemann Blumenthal, CEO of BELKIN Laser, Ltd., discusses the company's current initiative of developing an automated one-second laser therapy for glaucoma called direct selective laser trabeculoplasty (DSLT).

Patient expectations continue to push clinicians to look at optimal ways to arrive at the best IOLs.